Please login to the form below

Not currently logged in
Email:
Password:

paclitaxel

This page shows the latest paclitaxel news and features for those working in and with pharma, biotech and healthcare.

Chi-Med and Lilly’s cancer drug Elunate a milestone for China

Chi-Med and Lilly’s cancer drug Elunate a milestone for China

Chi-Med has a pivotal phase 3 trial of fruquintinib as a second line combination with paclitaxel in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma due in the first

Latest news

More from news
Approximately 9 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    Sorrento (Igdrasol)/ NantPharma. Asset acquisition. Acquisition of Igdrasol including Cynviloq (paclitaxel nanoparticle).

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    For late-stage patients, Brazil physicians are more likely to use an anthracycline-based regimen without a taxane in the first line, gemcitabine, paclitaxel or a combination of both in the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • BMS appoints oncology development head BMS appoints oncology development head

    Dr Namouni first joined Bristol-Myers Squibb in France in 1999 as a life-cycle manager for chemotherapy drug Taxol (paclitaxel) and has since held a number of increasingly senior positions

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics